This study was supported by the Beijing Hospitals Authority Youth
Program (No. QML20180203), The Priming Scientific Research
Foundation for the Junior Researcher in Beijing Tongren Hospital,
Capital Medical University (No. 2018‐YJJ‐ZZL‐043), Beijing Natural
Science Foundation (No. 7194248), Beijing Dongcheng District
Excellent Talent Training Subsidy Project‐Youth Backbone Individual
Program and Beijing Advanced Innovation Center for Big Data‐Based
Precision Medicine, Beijing Tongren Hospital, Beihang University and
Capital Medical University (No. BHTR‐KFJJ‐202011).
第一作者机构:[1]Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[1]Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China[*1]Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
推荐引用方式(GB/T 7714):
Xu Yingchen,Zhang Dongxin,Ji Jiajun,et al.Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation[J].MOLECULAR CARCINOGENESIS.2023,62(7):1062-1072.doi:10.1002/mc.23546.
APA:
Xu Yingchen,Zhang Dongxin,Ji Jiajun&Zhang Lijun.(2023).Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation.MOLECULAR CARCINOGENESIS,62,(7)
MLA:
Xu Yingchen,et al."Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation".MOLECULAR CARCINOGENESIS 62..7(2023):1062-1072